Product Design and Manufacturer

Clinical Diagnostics and Life Science Research Providers
ShanghaiJuly 25, 2023PR Newswire -- Recently, the first locally produced mass spectrometry product in China by SCIEX, an innovator in life science analytical technologies and a Danaher company, was officially delivered. This series includes the SCIEX 4500 Series Mass Spectrometry Systems (including the SCIEX Triple Quad™ and QTRAP® Systems), and the SCIEX Triple Quad™ 5500+ System (with QTRAP® Ready functionality). The systems were successfully installed in the SCIEX demonstration laboratory at Danaher's Shanghai headquarters. The localized production of SCIEX’s mass spectrometry products marks another milestone in Danaher's "Creating and Elevating in China" localization strategy. It not only significantly reduces the time gap for innovative products to reach China, achieving "zero-time difference" service, but also provides domestic customers with a refined and efficient user experience, supporting the development of a healthy industry ecosystem centered around mass spectrometry.
"Localization" of Production Takes the Lead, Accelerating Response to the Chinese Market
Due to their superior characteristics of higher resolution, higher sensitivity, higher throughput, and higher accuracy, mass spectrometry products, as high-end experimental analytical instruments, are acclaimed as the "crown jewel" in the industry. They have been widely applied in various fields such as pharmaceutical analysis, food safety, and environmental monitoring. The rapid development of testing demands across multiple industries has also expanded the market size of the mass spectrometry sector. According to the "2021-2027 China Clinical Mass Spectrometry Testing Industry Development Strategy and In-depth Research Report" published by the China Research Institute, driven by the demand from downstream application areas, the global mass spectrometry product market will maintain steady growth. It is projected that the market size will reach 11.2 billion US dollars by 2026, with a compound annual growth rate (CAGR) of 7.7% from 2018 to 2026.
In the Chinese market, the mass spectrometry industry is also gradually entering a fast lane of development. According to the "2022 Global Mass Spectrometer Market Report" published by GIR (Global Info Research), which covers overall scale, major companies, key regions, products, and application segments, the market size of China's mass spectrometry industry reached 14.22 billion yuan in 2020, increasing by 11.3% year-on-year. By 2021, the market size of domestically produced mass spectrometry products had grown to approximately 15 billion yuan, accounting for about 30% of the global market. At the same time, in recent years, the Chinese government has introduced a series of supportive policies to promote high-quality development in the mass spectrometry industry. The "14th Five-Year Plan" explicitly emphasized strengthening the research and manufacturing of high-end scientific analytical instruments.

SCIEX China Team Celebrates the Delivery of the First Mass Spectrometry Product Made in China
To better serve customers in China and promote human health, SCIEX actively promotes the implementation of localized product projects.Jianhua Wu, Director of Strategic Solutions, SCIEX ChinaStated: "The localized product of SCIEX this time originates from the classic design of the industry-renowned commercial mass spectrometry system, inheriting the excellent quality of SCIEX mass spectrometers, and is endowed with the unique reliability, accuracy, and sensitivity characteristic of the SCIEX brand. At the same time, SCIEX China is also continuously committed to building a technology ecosystem centered on mass spectrometry and expanding the boundaries of innovation."
At the same time, under the guidance of Danaher Corporation's "Made in China" localization strategy, building a mass spectrometry industry ecosystem with local decision-making, local R&D, local production, and local services can respond more quickly to the incremental market demands of China’s mass spectrometry industry. As the first step in the local supply chain, localized production is of great significance to SCIEX.
Shorten the Decision Chain, Deeply Integrate the "Create and Elevate China" Strategy
Centering on local customer needs, Danaher closely integrates local innovation, local manufacturing, and local commercialization, actively leveraging the unique advantages of its DBS business system to continuously drive innovation and empower industrial development through a virtuous cycle. This forms the core of Danaher's "Creating and Elevating China" localization strategy.
In the "8080" quantitative targets of the "Create and Elevate China" strategy, it is proposed that 80% of future product sales in China will be produced in China; 80% of the raw materials and components used by local factories will be procured domestically, thereby fully realizing self-sufficiency in the internal cycle.InXiaoliang Sang, Vice President of SCIEX and General Manager of ChinaIt seems that: "The delivery of this mass spectrometry product has brought the ‘8080’ goal one step closer. Moving closer to customers and responding to their needs with ‘zero time difference’ has always been SCIEX’s philosophy. SCIEX has always valued the voice of its users. Through in-depth, ‘zero distance’ communication with our customers, we listen to their real needs and feedback. The voice of the users not only helps us develop products that better meet actual needs, but some of their ideas also, in turn, promote SCIEX's development and innovation, making it a win-win growth process."
A deeper understanding of the local market and high-quality innovative talent with expertise in local operations are crucial to fully implementing Danaher's "Create and Elevate China" localization strategy. As the leader of SCIEX in China, Sang Xiaoliang understands this well: "Under Danaher’s excellent DBS management system, SCIEX has become more open in building a localized talent team—not only focusing on recruiting talent but also empowering SCIEX partners by creating a talent ecosystem." Sang Xiaoliang also mentioned that, to achieve more flexible localized market operations, in addition to talent development, Danaher has made significant adjustments to its organizational structure by integrating its businesses in China under unified leadership, enhancing synergistic development across different product line operating companies to uncover innovative opportunities and meet specific demands of the Chinese market. For example, there may be closer cooperation and connection between Danaher's operating companies and SCIEX, leveraging their respective strengths and accumulated resources to better serve customers.
If the localization of highly skilled talents and localized operational structures have brought more flexibility to SCIEX in business, standardized production processes and strict quality control ensure the superior quality of SCIEX’s locally manufactured products. Consistently, SCIEX has always upheld the fastidious corporate DNA of Danaher Corporation, maintaining alignment with globally authoritative certifications for quality management systems, environmental management systems, and occupational health and safety management systems. "SCIEX's local manufacturing facility boasts an excellent production management system module, adopting unified global standards in R&D, procurement, and quality. The product quality meets the high standards required for the global market, ensuring that the mass spectrometry products provided to local users enjoy the same high quality as those in the global market," emphasized Xiao Liang Sang.
Continuously Break Through Innovation Boundaries and Strengthen the Concept of High-Quality After-Sales Service
In the quantitative field, SCIEX has become an industry leader due to its product robustness, reliability, high sensitivity, and high precision. It continues to increase R&D investment and innovation, driving growth with cutting-edge technology and products.Kerong Zhang, Director of Strategic Marketing, SCIEX China"This delivery of the first locally-produced mass spectrometry product in China is a new testament to SCIEX’s boundary-pushing innovation. SCIEX integrates its brand attributes into multiple product lines, including the mass spectrometry field, and is committed to forging the brand as the preferred partner for all quantitation-related end-user markets."
To maintain SCIEX's innovative position in the industry, cutting-edge technology is the crucial first step. SCIEX consistently engages in communication activities with various customers, and recent innovations by SCIEX have been discussed alongside its technologies or workflows. Many of SCIEX’s existing customers are senior scientists, while the younger generation of future scientists will bring more ideas and potential, driving SCIEX to achieve further innovation. SCIEX always supports collaboration and innovation with customers in China and believes that the products needed in China will ultimately serve other regions of the world.
In addition, comprehensive support from an after-sales service team is also indispensable. "Product sales do not mark the end, but rather the beginning of service. SCIEX has established a dedicated after-sales team to serve users, providing support software or software updates, or optimizing users' laboratories, among other things. Quality service will continue to be one of SCIEX's most focused areas."Zhang Kerong said。
In the future, under the guidance of Danaher's "Advance China" localization strategy, SCIEX will continue to focus on building a local industrial ecosystem centered on mass spectrometry. It will accelerate the pace of localized production, localized supply chain, localized open innovation, and localized business decision-making. Continuously pushing the boundaries of innovation, it aims to provide high-quality mass spectrometry products that better meet user needs, serve Chinese users more effectively, drive industry development, and harness the power of precise analysis to transform everyone’s lives.